Stay updated on Ipilimumab+Nivolumab for Stage IV IBC Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab+Nivolumab for Stage IV IBC Clinical Trial page.

Latest updates to the Ipilimumab+Nivolumab for Stage IV IBC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3, indicating a minor update to the page. This change likely reflects a small patch to metadata or layout rather than any change to the study details or content.SummaryDifference0.0%

- Check23 days agoChange DetectedA new page revision identifier v3.6.2 has been added to the page. The previous v3.6.0 revision has been removed.SummaryDifference0.0%

- Check38 days agoChange DetectedThe recruitment status was updated to indicate no participants are being sought, signaling that enrollment has ended. Additional sections and navigational elements—How to Read a Study Record, Common Questions, How to Join a Study, and the Intervention/Treatment heading—were added, and the page revision shows v3.6.0.SummaryDifference0.5%

- Check45 days agoChange DetectedRevision: v3.5.5 has replaced v3.5.4, signaling a new deployment of page updates.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page now shows a newer revision tag, v3.5.4. The previous tag, v3.5.3, has been removed, signaling a minor metadata update to the page.SummaryDifference0.0%

- Check81 days agoChange DetectedRevision metadata updated from v3.5.2 to v3.5.3, indicating a new version of the page. This is a maintenance/version update that does not alter the study details or content.SummaryDifference0.0%

Stay in the know with updates to Ipilimumab+Nivolumab for Stage IV IBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab+Nivolumab for Stage IV IBC Clinical Trial page.